NYSE:RDY
Dr Reddy's Laboratories Ltd Stock News
$74.88
-0.330 (-0.439%)
At Close: May 06, 2024
Dr. Reddy's Laboratories Limited's (RDY) CEO Erez Israeli on Q1 2023 Results - Earnings Call Transcript
01:03am, Sunday, 31'st Jul 2022
Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q1 2023 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Parag Agar
Dr. Reddy's (RDY) Q1 Earnings Increase Y/Y, Sales Increase
08:28pm, Friday, 29'th Jul 2022 Zacks Investment Research
Dr. Reddy's (RDY) earnings and sales increase year over year in first-quarter fiscal 2023.
Dr. Reddy's (RDY) Q1 Earnings Increase Y/Y, Sales Increase
06:39pm, Friday, 29'th Jul 2022
Dr. Reddy's (RDY) earnings and sales increase year over year in first-quarter fiscal 2023.
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase
01:50pm, Friday, 20'th May 2022 Zacks Investment Research
Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2022.
New Strong Sell Stocks for May 20th
10:37am, Friday, 20'th May 2022 Zacks Investment Research
Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.
New Strong Sell Stocks for May 20th
08:17am, Friday, 20'th May 2022
Teaser: CBAN, CHUY, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2022.
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q4 2022 Results - Earnings Call Transcript
05:03pm, Thursday, 19'th May 2022
Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q4 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Gunupati Pr
New Strong Sell Stocks for May 18th
11:36am, Wednesday, 18'th May 2022 Zacks Investment Research
ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.
New Strong Sell Stocks for May 18th
09:02am, Wednesday, 18'th May 2022
ALX, CBAN, and RDY have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2022.
New Strong Sell Stocks for May 12th
10:30am, Thursday, 12'th May 2022 Zacks Investment Research
CHUY, RDY, and FBC have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2022.
New Strong Sell Stocks for May 12th
07:32am, Thursday, 12'th May 2022
CHUY, RDY, and FBC have been added to the Zacks Rank #5 (Strong Sell) List on May 12, 2022.
Board of Dr Reddys Laboratories appoints company secretary and compliance officer
06:53am, Thursday, 17'th Mar 2022 Business Standard
At meeting held on 17 March 2022
Sensex jumps 309.91 points in early trade; Nifty above 16,700
04:33am, Monday, 14'th Mar 2022 The Tribune
Mumbai, March 14 Benchmark indices Sensex and Nifty surged higher in the opening trade on Monday, helped by heavy buying in IT counters amid a mixed trend in Asian markets. Rising for the fifth straight session, the BSE benchmark Sensex jumped 309.91 points to 55,860.21. Similarly, the broader NSE Nifty also climbed 72.1 points to 16,702.55. In the 30-share Sensex pack, Infosys, HDFC Bank, Tech Mahindra, Wipro and State Bank of India were the major gainers. In contrast, Hindustan Unilever Limited, Mahindra amp; Mahindra, Bajaj Finance and Dr Reddy''s Laboratories were among the laggards. On Friday, the 30-share BSE Sensex had settled 85.91 points or 0.15 per cent higher at 55,550.30. The broader NSE Nifty gained 35.55 points or 0.21 per cent to close at 16,630.45. Bourses in Hong Kong and Shanghai were quoting lower, while Tokyo was trading higher during the mid-session deals. Stock exchanges in the US settled lower on Friday. Meanwhile, international oil benchmark Brent crude dipped 2.
Indian cos stay put in Russia but pharma exports could be hit
05:58pm, Wednesday, 09'th Mar 2022 The Times of India
Pharmaceutical major Dr Reddy''s Laboratories said on Wednesday it was focused on business continuity in and around Russia, as Indian drug exporters brace for temporary disruptions to sales due to the Ukraine crisis.
4 pharma & metal stocks to buy now: Rahul Shah
04:11am, Wednesday, 09'th Mar 2022 Economic Times India
“Dr Reddys and Sun Pharma looks quite promising in the pharma pack. The recent correction in the market has given a decent room for a near-term upside. In the metal pack, Tata Steel looks like a value play from here. Vedanta also could do very well and the valuation looks quite promising.”